Literature DB >> 11129333

Age- and tissue-specific variation of X chromosome inactivation ratios in normal women.

A Sharp1, D Robinson, P Jacobs.   

Abstract

The incidence of skewed X-inactivation in normal women is controversial, with up to 10-fold differences being reported by different authors. In order to clarify this issue, we have conducted a survey of the X-inactivation patterns in 270 informative females from various age groups, using the androgen receptor gene/polymerase chain reaction assay. Results obtained by using DNA extracted from blood samples show that the incidence of severe skewing (defined here as ratios > or = 90:10) is relatively common and increases with age (P<0.05), occurring in 7% of women under 25 years of age, and 16% of women over 60. In order to study tissue-specific patterns of X-inactivation, samples of both buccal and urinary epithelia were also obtained from 88 of the females studied. Although there was a significant association of the X-inactivation ratios between each tissue in most individuals, wide variations were apparent in some cases, making accurate extrapolations between tissues impossible. The degree of correlation between each tissue also fell markedly with age. Our data are consistent with the hypothesis that the major factors in the aetiology of skewed X-inactivation are secondary selection processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129333     DOI: 10.1007/s004390000382

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  100 in total

1.  A longitudinal study of X-inactivation ratio in human females.

Authors:  Ionel Sandovici; Anna K Naumova; Mark Leppert; Yendi Linares; Carmen Sapienza
Journal:  Hum Genet       Date:  2004-08-28       Impact factor: 4.132

2.  The Role of X-Chromosome Inactivation in Retinal Development and Disease.

Authors:  Abigail T Fahim; Stephen P Daiger
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

3.  Extremely skewed X-chromosome inactivation is increased in pre-eclampsia.

Authors:  Elif Uz; Ismail Dolen; Atakan R Al; Tayfun Ozcelik
Journal:  Hum Genet       Date:  2006-11-07       Impact factor: 4.132

4.  Heterozygote BRCA1 status and skewed chromosome X inactivation.

Authors:  Anne Helbling-Leclere; Gilbert M Lenoir; Jean Feunteun
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

5.  X chromosome-inactivation patterns of 1,005 phenotypically unaffected females.

Authors:  James M Amos-Landgraf; Amy Cottle; Robert M Plenge; Mike Friez; Charles E Schwartz; John Longshore; Huntington F Willard
Journal:  Am J Hum Genet       Date:  2006-07-27       Impact factor: 11.025

6.  No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans.

Authors:  Véronique Bolduc; Pierre Chagnon; Sylvie Provost; Marie-Pierre Dubé; Claude Belisle; Marianne Gingras; Luigina Mollica; Lambert Busque
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 7.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

8.  Small genomic rearrangements involving FMR1 support the importance of its gene dosage for normal neurocognitive function.

Authors:  Sandesh C S Nagamani; Ayelet Erez; Frank J Probst; Patricia Bader; Patricia Evans; Linda A Baker; Ping Fang; Terry Bertin; Patricia Hixson; Pawel Stankiewicz; David Nelson; Ankita Patel; Sau Wai Cheung
Journal:  Neurogenetics       Date:  2012-08-14       Impact factor: 2.660

9.  Functional disomy resulting from duplications of distal Xq in four unrelated patients.

Authors:  Katherine L Lachlan; Morag N Collinson; Richard O C Sandford; Berendine van Zyl; Patricia A Jacobs; N Simon Thomas
Journal:  Hum Genet       Date:  2004-08-24       Impact factor: 4.132

10.  Pharmacoepigenetics of depression: no major influence of MAO-A DNA methylation on treatment response.

Authors:  Katharina Domschke; Nicola Tidow; Kathrin Schwarte; Christiane Ziegler; Klaus-Peter Lesch; Jürgen Deckert; Volker Arolt; Peter Zwanzger; Bernhard T Baune
Journal:  J Neural Transm (Vienna)       Date:  2014-05-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.